In conclusion, our study showed that melatonin promoted CYP19A1 and HO-1 expression, reducing IL-18 levels in human ovarian GCs to facilitate oocyte maturation from a PCOS patient with hyperandrogenia (Figure 8). Here, CYP19A1 is linked to polycystic ovary syndrome.